Jane Martin, PhD
- ASSOCIATE CLINICAL PROFESSOR | Psychiatry
Specialties:Psychology, Alzheimer's Disease
Research Topic:Alzheimer's Disease
Dr. Martin is an Associate Professor of Psychiatry and Director of the Clinical Neuropsychology Division in the Department of Psychiatry at the Mount Sinai School of Medicine. She is the Director of the Neuropsychology Testing and Evaluation Center (Neuropsychology Services) and the Adult Psychology Pre-doctoral Training Program in the Department of Psychiatry. She received her Ph.D. in Psychology from New York University and completed a post-doctoral fellowship in Neuropsychology at Mount Sinai School of Medicine. She teaches in the Memory Enhancement Program, a wellness program for older adults, and also maintains a psychotherapy practice. Dr. Martin is a neuropsychologist at Mount Sinai's Alzheimer's Disease Research Center (ADRC), as well as being an accomplished clinician and administrator of neuropsychological clinical services.
As Director of the Neuropsychological Testing and Evaluation Center, she provides neuropsychological assessment for memory disorders and teaches, "Introduction to Neuropsychological Assessment in Psychiatry and Geriatric Psychiatry". Dr. Martin conducts and supervises neuropsychological assessments, in addition to teaching and lecturing on the topic of neuropsychological testing and memory and aging. Dr. Martin's research interests include healthy aging in the elderly, Alzheimer's disease and related dementias, and women's cognitive changes throughout the lifespan. She receives research support from Mount Sinai's ADRC (Alzheimer's Disease Research Center) and the ADCS Project (Alzheimer's Disease Cooperative Study Site). Currently, she is Co-Investigator for a study about the Therapeutic Effects of Exercise in Adults with Amnestic Mild Cognitive Impairment at the ADRC (GCO # in process) as well as Co-Investigator for A Phase 2 Multi Center, Randomized, Double Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients with Mild to Moderate Alzheimer’s Disease (GCO#91-208) and Co-Investigator for A Double Blind, Randomized, Placebo Controlled, Parallel Group Study to Simultaneously Qualify a Biomarker Algorithm for Prognosis of Risk of Developing Mild Cognitive Impairment due to Alzheimer’s Disease (MCI due to AD) and to Test the Safety and Efficacy of Pioglitazone (AD 4833SR 0.8mg QD) to Delay the Onset of MCI due to AD in Cognitively Normal Subjects (TOMM40) (GCO# 13-1688). She wass PI for a multi-center 4-year longitudinal study to evaluate home-based methods for Alzheimer's disease prevention research (GCO #91-208(13) and is the center neuropsychologist and co-investigator for a study of deep brain stimulation for treatment of obsessive compulsive disorder (GCO #09-1479) in the department of Psychiatry.
Financial & Billing Information
Please direct any detailed billing or financial inquires to the Mount Sinai Psychiatry billing customer service number at 212-659-8752.
- Alzheimer's Disease
PHD, New York University
Internship, Psychology, Mount Sinai Hospital
Fellowship, Neuropsychology, Mount Sinai Hospital
Memory and Aging, Neuropsychology of Alzheimer's disease and related Dementias